U.S. Physical Therapy (NYSE:USPH) Stock Price Target Raised at Barrington Research

U.S. Physical Therapy (NYSE:USPH) had its target price increased by Barrington Research from $98.00 to $110.00 in a research note issued to investors on Friday morning,Benzinga reports. The brokerage currently has an outperform rating on the stock.

Several other equities research analysts also recently issued reports on the company. Citigroup reaffirmed a “market outperform” rating on shares of U.S. Physical Therapy in a report on Wednesday, August 19th. JPMorgan Chase & Co. raised their price target on shares of U.S. Physical Therapy from $90.00 to $95.00 and gave the company an “overweight” rating in a research note on Friday, September 11th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of U.S. Physical Therapy in a report on Wednesday, August 26th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $101.25.

U.S. Physical Therapy Stock Up 2.9%

Shares of NYSE USPH traded up $2.81 during midday trading on Friday, reaching $100.02. The company’s stock had a trading volume of 295,068 shares, compared to its average volume of 166,055. The stock has a 50 day simple moving average of $84.20 and a 200-day simple moving average of $77.04. U.S. Physical Therapy has a fifty-two week low of $58.19 and a fifty-two week high of $101.18. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $1.49 billion, a price-to-earnings ratio of -74.09, a PEG ratio of 2.16 and a beta of 1.16.

U.S. Physical Therapy (NYSE:USPH) last released its earnings results on Wednesday, November 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.76 by $0.04. The business had revenue of $222.56 million for the quarter, compared to analyst estimates of $214.48 million. U.S. Physical Therapy had a return on equity of 9.39% and a net margin of 3.97%. U.S. Physical Therapy’s revenue was up 12.9% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.66 earnings per share. Equities research analysts predict that U.S. Physical Therapy will post 2.89 earnings per share for the current year.

U.S. Physical Therapy Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 11th. Shareholders of record on Monday, November 16th will be paid a $0.46 dividend. This represents a $1.84 dividend on an annualized basis and a yield of 1.8%. The ex-dividend date is Monday, November 16th. U.S. Physical Therapy’s dividend payout ratio is 1,082.35%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. BlackRock Inc. purchased a new stake in U.S. Physical Therapy during the 2nd quarter worth about $155,505,000. William Blair Investment Management LLC purchased a new stake in shares of U.S. Physical Therapy during the second quarter valued at approximately $30,013,000. Bank of America Corp DE bought a new position in shares of U.S. Physical Therapy during the second quarter valued at about $19,381,000. Bank of New York Mellon Corp purchased a new stake in U.S. Physical Therapy in the 2nd quarter worth approximately $9,087,000. Finally, Copeland Capital Management LLC lifted its holdings in U.S. Physical Therapy by 11.8% in the third quarter. Copeland Capital Management LLC now owns 940,528 shares of the company’s stock worth $80,632,000 after buying an additional 98,984 shares during the period.

U.S. Physical Therapy News Summary

Here are the key news stories impacting U.S. Physical Therapy this week:

• Positive Sentiment: USPH reported third-quarter earnings of $0.80 per share, ahead of the $0.76 consensus estimate, while revenue of $222.56 million topped expectations of $214.48 million and increased 12.9% year over year. U.S. Physical Therapy Tops Q3 Earnings and Revenue Estimates
• Positive Sentiment: Management reaffirmed full-year EBITDA guidance of $102 million to $106 million. Hospital revenue grew to more than 13%, offering another sign of business momentum. USPH Reaffirms EBITDA Guidance as Hospital Revenue Rises
• Positive Sentiment: Barrington Research raised its price target from $98 to $110 and maintained an “outperform” rating, signaling increased analyst confidence. Barrington Research Recommendations
• Positive Sentiment: The board declared a quarterly dividend of $0.46 per share, payable December 11 to shareholders of record November 16. The annualized dividend is $1.84, equivalent to a 2.1% yield at the cited share price. US Physical Therapy Declares New Quarterly Dividend

About U.S. Physical Therapy

U.S. Physical Therapy, Inc (NYSE: USPH) operates outpatient physical therapy clinics throughout the United States. The company provides treatment and rehabilitation services for patients recovering from injuries, surgeries, illnesses and other conditions that affect movement, strength and physical function.

In addition to company-operated clinics, U.S. Physical Therapy develops and manages physical therapy practices in partnership with local physical therapists. Its services generally include orthopedic and sports rehabilitation, post-operative therapy, treatment for musculoskeletal conditions and other forms of outpatient rehabilitation.